Overview
SemaPen have developed a fully digital, remotely monitored tier 3 service. There are two patient pathways.
- The SemaHealth Programme - meal replacement VLCD plus digital physio/exercise with wraparound professional support and education.
 -  The SemaPen Programme - 
 all the benefits of the SemaHealth Programme, substituting VLCD for GLP-1 Agonist medication.
 
What patients see
The app experience
Simple, supportive and built for adherence. Patients use the SemaPen app to complete onboarding, track progress and access structured learning and community support — all without clinic visits.

Patient dashboard (at-a-glance progress)
 
Weight trend (auto-synced from smart scales)
 

Comorbidity tracking
(15 major obesity related conditions)
 

Personalised online physio/exercise coach
 

Patient dashboard (at-a-glance progress)
 
Weight trend (auto-synced from smart scales)
 

Academy lesson tiles
 

“Badge earned” confirmation
 
SemaHealth Programme
Complete meal replacement + behaviour change, fully remote. (12 months).
The SemaHealth programme combines three months of total diet replacement (Altralife) followed by food reintroduction, delivered alongside:
- Cloud-linked smart scales for continuous remote monitoring by SemaPen team
 - Comorbidity tracking of 15 major conditions (Every three months)
 - Personalised physio/exercise coaching
 - The SemaPen Academy (nutrition, mindfulness, “fitness without the gym”)
 - A food logger/tracker
 - A moderated patient forum
 - Light gamification (digital badges)
 
Typical outcome: patients can expect 12–15% average weight loss over 12 months¹.
Who it suits:  patients referred by GPs where medication is not appropriate or not preferred, or where a non-drug pathway is clinically indicated.
SemaPen Programme
GLP-1 digital programme for eligible patients.
We support medically supervised Wegovy (semaglutide) and Mounjaro (tirzepatide) treatment within a digital model designed to maximise adherence and safety.
The SemaPen programme runs for up to two years and includes all the benefits of the SemaHealth programme, substituting GLP-1 Agonists for VLCD.
Referral pathway for GPs
1. Refer via NHS secure email route (GP-to-service).
2. SemaPen approves the referral and creates the patient account the same day. A link is provided to the patient for onboarding.
3. The patient completes the standard onboarding flow, including a F2F video appointment to confirm clinical details and answer patient questions.
4. The patient proceeds directly into the appropriate programme. 
The option of patient self-referral is also available at the commissioner's discretion.
Face-to-face (remote) step
One video appointment during onboarding is used for ID checks and patient questions.
The remainder of care is entirely remote, reducing cost and improving patient compliance and convenience.
Patient communications
Patients can reach their dedicated support team 24 hours a day, 7 days a week through the in-app messaging system. Whether it’s a quick question, a medication concern, or a progress update, help is always just a message away.
They can also book or manage appointments with the clinical team directly from within the app. This includes choosing available time slots, receiving reminders, and viewing upcoming or past appointments in one convenient place.
Education: The SemaPen Academy
Structured, short-form lessons across:
Recipes & diet advice
Mindfulness for weight loss
Fitness without the gym
Content is reviewed by the SemaPen clinical team (including dieticians and psychologists). Patients earn digital badges as they complete modules, reinforcing positive habits.
Sword Health Move
NHS-referred patients also receive access to Sword Health’s Move programme for 10 months. This includes weekly, tailored movement plans with specialist oversight, using wearable devices provided as part of the programme, targeting inactivity and MSK risk while supporting overall cardiometabolic health.
Governance & infrastructure
Clinical oversight: from the highly experienced and trusted Phoenix Health clinical team of Doctors, Dieticians, Psychologists and Support Staff.
Regular MDT reviews support the remote SemaHealth and SemaPen Programmes, with the option of clinical escalation of any acute issues.
The Platform: 
 An MHRA-approved UK-hosted Laravel system built to meet 
NHS DSPT and UK GDPR standards. It uses 
Cloudflare protection, 
SSL/TLS encryption, and strict 
role-based access controls to safeguard patient data. All activity is 
fully logged and monitored, with 
regular security testing and 
UK-based backups ensuring reliability and patient safety.
Registration
SemaPen Pharmacy — GPhC 9012927.
Programme delivery includes pharmacy governance aligned to UK standards.
1-14474096275
Benefits of the SemaHealth and SemaPen Programmes
Fully digital T3 without compromising clinical quality
Minimal primary care burden
Ease of access
Continuous monitoring
Meaningful results
Choice of GLP-1 or VLCD programmes with clinically proven outcomes.
Holistic wrap-around support
Uses three proven methods:
- Calorie restriction
 - Physical exercise
 - Motivational psychology
 
